Production (Stage)
Barinthus Biotherapeutics plc
BRNS
$0.875
$0.0455.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.43% | 4.30% | -9.91% | -9.38% | -8.53% |
| Total Receivables | -45.97% | -66.04% | 271.06% | -11.36% | -19.49% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.47% | -17.06% | -9.59% | 53.41% | -5.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -8.93% | 348.71% | -25.88% | -62.63% | 13.64% |
| Total Current Assets | -12.61% | -6.62% | 2.10% | -7.86% | -8.78% |
|
|
|||||
| Total Current Assets | -12.61% | -6.62% | 2.10% | -7.86% | -8.78% |
| Net Property, Plant & Equipment | -14.47% | -35.27% | -0.47% | -3.65% | -2.38% |
| Long-term Investments | -- | -- | 0.00% | 0.00% | 0.00% |
| Goodwill | -- | -- | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -3.60% | -3.47% | -3.36% | -3.25% | -3.15% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.38% | -4.86% | 4.51% | 0.11% | 0.34% |
| Total Assets | -11.43% | -15.03% | 1.04% | -6.38% | -7.00% |
|
|
|||||
| Total Accounts Payable | -45.15% | -19.57% | 20.34% | 119.97% | -27.42% |
| Total Accrued Expenses | -24.43% | 19.57% | -22.49% | 23.39% | -9.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.08% | -3.32% | 3.65% | 0.37% | 6.95% |
| Total Finance Division Other Current Liabilities | -15.94% | -14.97% | 143.62% | -41.49% | -- |
| Total Other Current Liabilities | -15.94% | -14.97% | 143.62% | -41.49% | -- |
| Total Current Liabilities | -23.51% | 3.88% | -3.32% | 21.46% | 1.88% |
|
|
|||||
| Total Current Liabilities | -23.51% | 3.88% | -3.32% | 21.46% | 1.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.27% | -5.58% | 0.27% | -2.23% | -2.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.45% | 28.07% | -6.54% | -0.48% | 0.32% |
| Total Liabilities | -12.55% | 3.30% | -2.44% | 9.08% | -0.16% |
|
|
|||||
| Common Stock & APIC | 0.12% | 0.41% | 0.41% | 0.40% | 0.55% |
| Retained Earnings | -8.27% | -9.46% | -3.88% | -8.81% | -8.77% |
| Treasury Stock & Other | 18.01% | -66.71% | 37.25% | 0.66% | -6.80% |
| Total Common Equity | -11.18% | -18.37% | 1.71% | -8.85% | -8.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.18% | -18.37% | 1.71% | -8.85% | -8.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -6.60% | -36.53% | -2.91% | -6.01% | -13.27% |
| Total Equity | -11.17% | -18.39% | 1.70% | -8.85% | -8.01% |
|
|
|||||